Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (21-30 of 497) with videos related to

Pageof 50
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 7, 2015
Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studiesLuigi Celio, Erminio Bonizzoni, Filippo De Braud, et al.
Expert Review of Anticancer Therapy|August 28, 2014
Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancerRoberto Iacovelli, Matteo Santoni, Filippo de Braud, et al.
Critical Reviews in Oncology/Hematology|July 28, 2004
Colon cancerRoberto Labianca, Giordano Beretta, Gemma Gatta, et al.
Tumori|June 9, 2012
New perspectives in advanced genitourinary malignanciesPamela Biondani, Giuseppe Procopio, Filippo Pietrantonio, et al.
Tumori|July 25, 2012
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapyLuigi Celio, Francesco Agustoni, Isabella Testa, et al.
Nature Communications|August 28, 2020
Fasting-mimicking diet plus chemotherapy in breast cancer treatmentClaudio Vernieri, Francesca Ligorio, Emma Zattarin, et al.
The Lancet. Oncology|August 21, 2019
Should we use combination therapy for all advanced renal cell carcinoma?Giuseppe Procopio, Pierangela Sepe, Melanie Claps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Tackling off-label use of anticancer drugsFrancesco Perrone, Filippo de Braud, Roberto Labianca, et al.
Breast (Edinburgh, Scotland)|March 17, 2015
Prognosis of women with early breast cancer and PIK3CA mutationsSerena Di Cosimo, Giulia Valeria Bianchi, Giacomo Bregni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
To target or not to target, that is the questionMarina Chiara Garassino, Marco Platania, Massimo Broggini, et al.
Pageof 50

Showing results (21-30 of 497) with videos related to

Sort By:
Pageof 50
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 7, 2015
Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studiesLuigi Celio, Erminio Bonizzoni, Filippo De Braud, et al.
Expert Review of Anticancer Therapy|August 28, 2014
Highlights from the ASCO Genitourinary Symposium 2014: focus on renal and prostate cancerRoberto Iacovelli, Matteo Santoni, Filippo de Braud, et al.
Critical Reviews in Oncology/Hematology|July 28, 2004
Colon cancerRoberto Labianca, Giordano Beretta, Gemma Gatta, et al.
Tumori|June 9, 2012
New perspectives in advanced genitourinary malignanciesPamela Biondani, Giuseppe Procopio, Filippo Pietrantonio, et al.
Tumori|July 25, 2012
Palonosetron: an evidence-based choice in prevention of nausea and vomiting induced by moderately emetogenic chemotherapyLuigi Celio, Francesco Agustoni, Isabella Testa, et al.
Nature Communications|August 28, 2020
Fasting-mimicking diet plus chemotherapy in breast cancer treatmentClaudio Vernieri, Francesca Ligorio, Emma Zattarin, et al.
The Lancet. Oncology|August 21, 2019
Should we use combination therapy for all advanced renal cell carcinoma?Giuseppe Procopio, Pierangela Sepe, Melanie Claps, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2012
Tackling off-label use of anticancer drugsFrancesco Perrone, Filippo de Braud, Roberto Labianca, et al.
Breast (Edinburgh, Scotland)|March 17, 2015
Prognosis of women with early breast cancer and PIK3CA mutationsSerena Di Cosimo, Giulia Valeria Bianchi, Giacomo Bregni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
To target or not to target, that is the questionMarina Chiara Garassino, Marco Platania, Massimo Broggini, et al.
Pageof 50